Clinical trial
Treatment of Thromboangiitis Obliterans (Buerger's Disease) With Bosentan
NCT01447550 is registered in ClinicalTrials.gov with Hospital Universitario Getafe as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Treatment of Thromboangiitis Obliterans (Buerger's Disease) With Bosentan
- Lead sponsor
- Hospital Universitario Getafe
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 31, 2009
- Completion date
- January 31, 2011
- Enrollment
- 12 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.